Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -168.25x is 488% below its 5-year average of -28.60x, around the middle of its 5-year range (-247.38x–-1.33x).
4.71% above its 12-month average of -176.56x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2026 (2026-03-31): -182.88x.
INTEREST COVERAGE RATIO
-168.25x
INTEREST COVERAGE RATIO AVG TTM
-176.56x
INTEREST COVERAGE RATIO AVG 3Y
-70.84x
INTEREST COVERAGE RATIO AVG 5Y
-28.60x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+4.71%
CURRENT VS 3Y AVG
-137.51%
CURRENT VS 5Y AVG
-488.28%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-2539.22%
vs the sector median at left
Shuttle Pharmaceuticals Holdings, Inc.
Market Cap
$2.38M
Interest Coverage Ratio
-168.25x
TTM Avg
-176.56x
3Y Avg
-70.84x
5Y Avg
-28.60x
Market Cap
$2.38M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.37M
Interest Coverage Ratio
-81.61x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.32M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.44M
Interest Coverage Ratio
673.25x
TTM Avg
673.25x
3Y Avg
673.25x
5Y Avg
673.25x
Market Cap
$2.54M
Interest Coverage Ratio
-238.27x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.56M
Interest Coverage Ratio
-1.05x
TTM Avg
65.98x
3Y Avg
65.98x
5Y Avg
65.98x
Market Cap
$2.14M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | $2.38M | -168.25x | -176.56x | -70.84x | -28.60x |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.38M | N/A | N/A | N/A | N/A |
| Onconetix, Inc. (ONCO)vs › | $2.37M | -8.45x | N/A | N/A | N/A |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.37M | -81.61x | N/A | N/A | N/A |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.32M | N/A | N/A | N/A | N/A |
| Jaguar Health, Inc. (JAGX)vs › | $2.44M | 673.25x | 673.25x | 673.25x | 673.25x |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.54M | -238.27x | N/A | N/A | N/A |
| Nuwellis, Inc. (NUWE)vs › | $2.56M | -1.05x | 65.98x | 65.98x | 65.98x |
| Vivos Therapeutics, Inc. (VVOS)vs › | $2.14M | N/A | N/A | N/A | N/A |
| GeoVax Labs, Inc. (GOVX)vs › | $2.13M | N/A | N/A | N/A | N/A |
Interest Coverage
-168.3x
Debt/Equity
0.01
Current Ratio
0.11
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | -182.88x |
| 2025-12-31 | -152.77x |
| 2025-09-30 | -119.92x |
| 2025-06-30 | -179.85x |
| 2025-03-31 | -247.38x |
| 2024-12-31 | -11.16x |
| 2024-09-30 | -11.19x |
| 2024-06-30 | -3.44x |
| 2024-03-31 | -2.78x |
| 2023-12-31 | -2.41x |
| 2023-09-30 | -2.56x |
| 2023-06-30 | -2.00x |
| 2023-03-31 | -2.56x |
| 2022-12-31 | -73.19x |
| 2022-09-30 | -1.33x |
| 2022-06-30 | -1.91x |
| 2022-03-31 | -4.09x |
| 2021-12-31 | -52.91x |
| 2021-09-30 | -22.71x |
| 2021-06-30 | -31.52x |
| 2021-03-31 | -16.34x |
